Related Articles
Inhibition of tumor growth and angiogenesis of tamoxifen‑resistant breast cancer cells by ruxolitinib, a selective JAK2 inhibitor
Differential effect of EGFR inhibitors on tamoxifen-resistant breast cancer cells
Curcumin inhibits LPS-induced EMT through downregulation of NF-κB-Snail signaling in breast cancer cells
EGFR inhibition reverses epithelial‑mesenchymal transition, and decreases tamoxifen resistance via Snail and Twist downregulation in breast cancer cells
Trichostatin A reverses epithelial‑mesenchymal transition and attenuates invasion and migration in MCF‑7 breast cancer cells